GABAergic modulation of performance in response inhibition and interference control tasks

Area of Science:

• Neuroscience
• Cognitive Psychology
• Psychopharmacology

Background:

• Inhibitory control is a key executive function impacting well-being.
• Neural mechanisms of inhibitory control, particularly the role of GABA, require further investigation.

Purpose of the Study:

• To investigate the effects of lorazepam, a GABAergic drug, on response inhibition and interference control.
• To explore the heterogeneity of inhibitory control and assess lorazepam's impact on the temporal dynamics of inhibition and activation.

Main Methods:

• A within-subjects, placebo-controlled, double-blind randomized design was used with 50 healthy participants.
• Participants performed antisaccade, Eriksen flanker, and Simon tasks.
• Lorazepam (0.5 mg and 1 mg) was administered to assess dose-dependent effects.

Main Results:

• Lorazepam dose-dependently increased reaction time and error rates across all tasks.
• The drug elevated congruency effects for error rates in antisaccade and Simon tasks, and for both error rates and reaction time in the Eriksen flanker task.
• Delta plots did not reveal drug-induced changes in temporal inhibition/activation, with task-dependent patterns observed.

Conclusions:

• Evidence supports GABAergic system involvement in response inhibition and interference control.
• Findings underscore the diverse nature of inhibitory control and task similarities.
• Delta plot analyses may not be sensitive to GABAergic modulation of cognitive processes.